{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:03:25Z","timestamp":1761541405516,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.brachy.2017.10.011","type":"journal-article","created":{"date-parts":[[2017,11,24]],"date-time":"2017-11-24T02:30:18Z","timestamp":1511490618000},"page":"319-325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["The impact of adjuvant vaginal brachytherapy in women with Stage II uterine endometrioid carcinoma: Results of a National Cancer Database analysis"],"prefix":"10.1016","volume":"17","author":[{"given":"Joon K.","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9074-9677","authenticated-orcid":false,"given":"Ahmed I.","family":"Ghanem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8418-5545","authenticated-orcid":false,"given":"Ankit","family":"Modh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Burmeister","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. Larry","family":"Maxwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed A.","family":"Elshaikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2017.10.011_bib1","first-page":"7","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.brachy.2017.10.011_bib2","first-page":"S105","article-title":"Carcinoma of the corpus uteri. FIGO 26th Annual Report on the results of treatment in gynecological cancer","volume":"95 Suppl 1","author":"Creasman","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.brachy.2017.10.011_bib3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ygyno.2008.06.008","article-title":"Adjuvant radiation for early stage endometrial cancer with lymphovascular invasion","volume":"111","author":"Croog","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2017.10.011_bib4","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/IGC.0000000000000018","article-title":"The impact of tumor grade on survival end points and patterns of recurrence of 949 patients with early-stage endometrioid carcinoma: A single institution study","volume":"24","author":"Gayar","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.brachy.2017.10.011_bib5","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1097\/01.AOG.0000260871.87607.25","article-title":"Clinical and pathologic correlates in surgical stage II endometrial carcinoma","volume":"109","author":"Cohn","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.brachy.2017.10.011_bib6","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1136\/ijgc-00009577-200111000-00002","article-title":"Clinical behavior of 203 stage II endometrial cancer cases: The impact of primary surgical approach and of adjuvant radiation therapy","volume":"11","author":"Sartori","year":"2001","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.brachy.2017.10.011_bib7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ijrobp.2007.09.022","article-title":"Stage II adenocarcinoma of the endometrium: Adjuvant radiotherapy and recurrence patterns","volume":"71","author":"Cozad","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.10.011_bib8","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ygyno.2008.12.029","article-title":"Outcomes following surgery and adjuvant radiation in stage II endometrial adenocarcinoma","volume":"113","author":"Cannon","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2017.10.011_bib9","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S0360-3016(02)02813-4","article-title":"Stage II endometrial carcinoma: Prognostic factors and risk classification in 170 patients","volume":"53","author":"Pitson","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.10.011_bib10","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijgo.2009.02.012","article-title":"Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium","volume":"105","author":"Pecorelli","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.brachy.2017.10.011_bib11","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.brachy.2016.06.012","article-title":"Trends in the utilization of adjuvant vaginal brachytherapy in women with early-stage endometrial carcinoma: Results of an updated period analysis of SEER data","volume":"15","author":"Modh","year":"2016","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2017.10.011_bib12","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.brachy.2011.08.005","article-title":"American Brachytherapy Society consensus guidelines for adjuvant vaginal cuff brachytherapy after hysterectomy","volume":"11","author":"Small","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2017.10.011_bib13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.brachy.2015.09.012","article-title":"Vaginal brachytherapy for postoperative endometrial cancer: 2014 Survey of the\u00a0American Brachytherapy Society","volume":"15","author":"Harkenrider","year":"2016","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2017.10.011_bib14","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ygyno.2014.12.012","article-title":"Recurrence patterns and survival endpoints in women with stage II uterine endometrioid carcinoma: A multi-institution study","volume":"136","author":"Elshaikh","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2017.10.011_bib15","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.ygyno.2005.04.030","article-title":"Stage II endometrial carcinoma: Limiting post-operative radiotherapy to the vaginal\u00a0vault in node-negative tumors","volume":"98","author":"Rittenberg","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2017.10.011_bib16","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1006\/gyno.2001.6130","article-title":"Postoperative vaginal vault brachytherapy for node-negative Stage II (occult) endometrial carcinoma","volume":"81","author":"Ng","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2017.10.011_bib17","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.brachy.2015.02.196","article-title":"Adjuvant radiotherapy in Stage II endometrial carcinoma: Is brachytherapy alone sufficient for local control?","volume":"14","author":"Paydar","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2017.10.011_bib18","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2016.6905","article-title":"Using the National Cancer\u00a0Database for outcomes Research: A review","author":"Boffa","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.brachy.2017.10.011_bib19","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/COC.0b013e3181b0c266","article-title":"Does brachytherapy improve survival in addition to external beam radiation therapy in patients with high risk stage I and II endometrial carcinoma?","volume":"33","author":"Crosby","year":"2010","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.brachy.2017.10.011_bib20","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1093\/jnci\/djt279","article-title":"Cause-specific effects of radiotherapy and lymphadenectomy in stage I-II endometrial cancer: A population-based study","volume":"105","author":"Mell","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.brachy.2017.10.011_bib21","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/COC.0000000000000065","article-title":"Adjuvant pelvic radiation therapy\u00b1vaginal brachytherapy in patients with high-risk stage I or stage II uterine papillary serous, clear cell, and high-grade endometrioid carcinoma","volume":"39","author":"Nagar","year":"2016","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.brachy.2017.10.011_bib22","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/COC.0000000000000129","article-title":"Influence of comorbidity on the risk of death: A single institution study of 1132 women with early-stage uterine cancer","volume":"40","author":"Elshaikh","year":"2017","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.brachy.2017.10.011_bib23","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","article-title":"Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: Multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma","volume":"355","author":"Creutzberg","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.brachy.2017.10.011_bib24","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","article-title":"A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: A Gynecologic Oncology Group study","volume":"92","author":"Keys","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2017.10.011_bib25","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0140-6736(08)61767-5","article-title":"Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): Pooled trial results, systematic review, and meta-analysis","volume":"373","author":"Blake","year":"2009","journal-title":"Lancet"},{"journal-title":"Int J Radiat Oncol Biol Phys","year":"2017","author":"Randall","key":"10.1016\/j.brachy.2017.10.011_bib26"},{"key":"10.1016\/j.brachy.2017.10.011_bib27","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ijrobp.2013.11.003","article-title":"Improved survival endpoints with adjuvant radiation treatment in patients with high-risk early-stage endometrial carcinoma","volume":"88","author":"Elshaikh","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.10.011_bib28","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1097\/IGC.0000000000001030","article-title":"Oncologic outcomes after adjuvant radiotherapy for stage II endometrial carcinoma: A Korean radiation oncology group study (KROG 14\u201310)","volume":"27","author":"Jung","year":"2017","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.brachy.2017.10.011_bib29","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/j.1525-1438.2007.01142.x","article-title":"Multicenter cohort study on treatment results and risk factors in stage II endometrial carcinoma","volume":"18","author":"Jobsen","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.brachy.2017.10.011_bib30","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ygyno.2009.03.007","article-title":"Stage II endometrioid adenocarcinoma of the endometrium: Clinical implications of cervical stromal invasion","volume":"113","author":"Orezzoli","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2017.10.011_bib31","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/0360-3016(91)90745-P","article-title":"Survival and failure analysis in stage II endometrial cancer using the revised 1988 FIGO staging system","volume":"21","author":"Reisinger","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.10.011_bib32","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1006\/gyno.1999.5380","article-title":"Predictors of recurrence in surgical stage II endometrial adenocarcinoma","volume":"73","author":"Feltmate","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2017.10.011_bib33","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1002\/cncr.22185","article-title":"Therapeutic role of lymph node resection in endometrioid corpus cancer: A study of 12,333 patients","volume":"107","author":"Chan","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.brachy.2017.10.011_bib34","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","article-title":"Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): An open-label, non-inferiority, randomised trial","volume":"375","author":"Nout","year":"2010","journal-title":"Lancet"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472117304865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472117304865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:13:51Z","timestamp":1761531231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472117304865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S1538472117304865"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2017.10.011","relation":{},"ISSN":["1538-4721"],"issn-type":[{"type":"print","value":"1538-4721"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of adjuvant vaginal brachytherapy in women with Stage II uterine endometrioid carcinoma: Results of a National Cancer Database analysis","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2017.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}